TAG:
pathology service
AP’s “High & Mighty” Firms Hit Tough Times
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: In the years between 1995 and 2002, public companies AmeriPath, DIANON Systems, and IMPATH built revenues and profits at a blistering pace. During this time period, these three firms captured enough market share to do almost $1 billion of anatomic pathology business in 2002. …
Entrepreneur Offers Private Pay Autopsies
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: For the past 14 years, a non-pathologist entrepreneur has enjoyed a growing business in offering autopsy services to clients willing to pay out-of-pocket. By design, the business is limited to the Southern California region. But demand in that region is enough to regularly en…
Genomic Health, LabCorp, DIANON Systems
By Robert Michel | From the Volume X No. 8 – June 16, 2003 Issue
GENETIC ANALYSIS FROM TISSUE BLOCKS UNVEILED IN CHICAGO IT WAS A SPECTACULAR DEBUT for a Northern California company now developing technology to allow genetic analysis of tissue blocks as a way to classify tumors. The company is Genomic Health, Inc., based in Redwood City,…
‘Health Lawyers News’ Attacks Pathology Part A
By Robert Michel | From the Volume X No. 7 – May 27, 2003 Issue
CEO SUMMARY: Pathologists should take time to read the cover story in the May 2003 issue of Health Lawyers News. Although the story nominally addresses questions involving how hospitals should reimburse physicians for administrative duties, it deals mostly with clinical pathology…
Eritrea Uses St. Louis For Reference Testing
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
CEO SUMMARY: On one level, it’s the classic story of volunteerism and help for a developing nation. But on another level, it’s a dramatic demonstration of how new technologies allow two hospital laboratories in St. Louis, Missouri to effectively provide reference laboratory tests and …
Specialty Laboratories, IMPATH, Roche, Abbott Laboratories, Celera Diagnostics
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
SPECIALTY LABORATORIES RESTORING STABILITY IN SPECIMEN VOLUME IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last …
LabCorp’s MacMahon Provides Insights About Lab Marketplace
By Robert Michel | From the Volume X No. 5 – April 14, 2003 Issue
CEO SUMMARY: Pathologists will be particularly interested in what Thomas MacMahon has to say about the evolution of laboratory medicine. As Chairman, President, and CEO of Laboratory Corporation of America Holdings, he has continuous access to some of the best strategic analysis about the…
Buyout of AmeriPath Riles Some Shareholders
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
CEO SUMMARY: Owners of the few remaining independent private laboratory companies closely watch prices paid by lab buyers. In the pending sale of AmeriPath to private equity investor Welsh, Carson, Anderson, & Stowe, dissenting shareholders disclosed several aspects of the valuation p…
“Where’s The Beef?” AP’s AWOL at AmeriPath
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
REMEMBER THAT FAMOUS TELEVISION commercial from Wendy’s burger restaurants? The elderly lady scrutinizes a big hamburger bun that’s obviously short on meat and asks the seminal question “Where’s the beef?” In 1984, it was a catch line that captured the American imagination and was repeated…
Carolina Blood Bank, PSA, Carolinas Healthcare, Leapfrog Group, CMS
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
PATHOLOGY GROUP IN SALT LAKE CITY BECOMES PSA MEMBER UTAH IS THE NEWEST STATE to have a pathology group practice become part of Pathology Service Associates, LLC (PSA). Based in Salt Lake City, Utah Pathology Services, Inc. is the first PSA-affiliated pract…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized